ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

BOLT Bolt Biotherapeutics Inc

1.08
-0.02 (-1.82%)
Fuera de horario
Última actualización: 15:30:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Bolt Biotherapeutics Inc BOLT NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.02 -1.82% 1.08 15:30:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.11 1.09 1.11 1.08 1.10
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
21/3/202415:05GLOBEBolt Biotherapeutics Reports Fourth Quarter and Full-Year..
06/3/202412:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202412:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202406:00GLOBEBolt Biotherapeutics to Present at the TD Cowen 44th Annual..
12/2/202420:41EDGAR2Form SC 13D/A - General statement of acquisition of..
06/2/202412:09EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
21/12/202306:30GLOBEPacira Appoints Frank D. Lee as Chief Executive Officer
13/12/202312:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202306:00GLOBEBolt Biotherapeutics Enrolls First Patient in Phase 2..
09/11/202315:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202315:08EDGAR2Form 8-K - Current report
09/11/202315:05GLOBEBolt Biotherapeutics Reports Third Quarter 2023 Financial..
07/11/202306:00GLOBEBolt Biotherapeutics to Present at Stifel 2023 Healthcare..
23/10/202309:30GLOBEBolt Biotherapeutics Presents Updated Clinical Data from..
18/10/202306:00GLOBEBolt Biotherapeutics to Present Data at the Society for..
17/10/202306:00GLOBEBolt Biotherapeutics Announces First Patient Dosed in Phase..
16/10/202306:00GLOBEBolt Biotherapeutics to Present New Clinical Data from..
28/9/202306:00GLOBEBolt Biotherapeutics Receives Orphan Drug Designation for..
12/9/202307:05GLOBEBolt Biotherapeutics Announces Issuance of U.S. Patent..
05/9/202315:15GLOBEBolt Biotherapeutics to Participate in September Investor..
07/8/202315:10GLOBEBolt Biotherapeutics Reports Second Quarter 2023 Financial..
07/8/202315:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202315:06EDGAR2Form 8-K - Current report
03/8/202306:30GLOBEBolt Biotherapeutics Initiates Phase 2 Clinical Studies of..
31/7/202316:27GLOBEBolt Biotherapeutics to Present at BTIG Virtual..
30/5/202307:00PRNUSBioLight announces a joint cooperation agreement with..
25/5/202316:05GLOBEBolt Biotherapeutics Highlights Comprehensive Clinical Data..
11/5/202315:05GLOBEBolt Biotherapeutics Reports First Quarter 2023 Financial..

Su Consulta Reciente

Delayed Upgrade Clock